{
    "2018-04-20": [
        [
            {
                "time": "",
                "original_text": "甘李药业称处于技术前沿，通化东宝表示不服气",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "技术前沿",
                        "通化东宝",
                        "不服气"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "多家药企布局第三代胰岛素，国产替代渐行渐近",
                "features": {
                    "keywords": [
                        "药企",
                        "第三代胰岛素",
                        "国产替代"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}